Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma
2000

Psychosocial Factors Affecting Melanoma Patients

Sample size: 426 publication Evidence: moderate

Author Information

Author(s): Brown J E, Butow P N, Culjak G, Coates A S, Dunn S M

Primary Institution: Medical Psychology Unit, University of Sydney

Hypothesis

Psychosocial factors can predict time to relapse and survival in early stage melanoma patients.

Conclusion

Psychosocial variables significantly influence the time to relapse and survival duration in melanoma patients.

Supporting Evidence

  • 62% of invited patients agreed to participate in the study.
  • 21% of participants relapsed and 14% died during the follow-up period.
  • Patients who perceived their treatment aim as being cured had longer periods without relapse.
  • Using avoidance as a coping strategy was linked to shorter survival duration.

Takeaway

This study found that how patients feel and cope with their illness can affect how long they live without their cancer coming back.

Methodology

Patients completed questionnaires every 3 months for 2 years, and data were analyzed using the Cox proportional hazards model.

Potential Biases

Potential bias from self-reported measures and the specific patient population studied.

Limitations

The study only included patients with locoregional melanoma and relied on self-reported data.

Participant Demographics

Patients with locoregional melanoma, tumor thickness exceeding 0.69 mm, seen at the Sydney Melanoma Unit between 1991 and 1996.

Digital Object Identifier (DOI)

10.1054/bjoc.2000.1471

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication